ImmunID, Scancell deal

The companies will use ImmunID’s ImmunTraCkeR test to predict which patients will respond to Scancell’s SCIB1, a cancer vaccine comprising the melanoma antigen tyrosinase-related protein 2 ( TRP-2;...